Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists
Neuroscience Discovery Chemistry, Research and Development, Bristol-Myers Squibb Co, Wallingford, CT 06492, United States. carolyn.dzierba@bms.com
Abstract:
Pyrido3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones were evaluated as corticotropin-releasing factor-1 receptor antagonists. The synthesis, SAR studies and pharmacokinetic evaluation of these analogs are described herein.